title: Alternative lipids to usual omega 6 PUFAS: gamma-linolenic acid, alpha-linolenic acid, stearidonic acid, EPA, etc.
abstract: The intravenous administration of parenteral fat emulsions is widely used in total parenteral nutrition (TPN) to supply essential fatty acids and concentrated energy in a relatively small volume of isotonic solution. They contain very high amounts of linoleic acid and usually about 8% of alpha-linolenic acid calculated in the fat phase (10 or 20% of the total emulsion). Most of the time one emulsion is given as the sole source of fat, giving direct venous entry to a fatty acid composition substantially different from that encountered in a normal diet. Since the latter greatly influences the fatty acid composition of phospholipids which are critical determinants of membrane structural properties influencing a variety of membrane functions (Fig. 1) (enzyme activity, membrane transport, receptor function) and functional precursors of intracellular and intercellular mediators (diacylglycerols, prostaglandins, leukotrienes, hydroxy fatty acids), do we provide the right fatty acid at the right place and the right time for efficient cell cell interaction? In other words, given the three roles of fatty acids--energetic, structural, functional--are we using the best strategy to avoid imbalances between the three roles?
authors.affiliation: Nestec Limited, Nestlé Research Centre, Lausanne, Switzerland.
authors.forename: D
authors.initials: D
authors.lastname: Spielmann
authors.forename: U
authors.initials: U
authors.lastname: Bracco
authors.forename: H
authors.initials: H
authors.lastname: Traitler
authors.forename: G
authors.initials: G
authors.lastname: Crozier
authors.forename: R
authors.initials: R
authors.lastname: Holman
authors.forename: M
authors.initials: M
authors.lastname: Ward
authors.forename: R
authors.initials: R
authors.lastname: Cotter
mesh_terms: D000818:Animals; D044943:Fatty Acid Desaturases / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D010289:Parenteral Nutrition, Total; D010743:Phospholipids / Q000378:metabolism; D013312:Stress, Physiological / Q000378:metabolism / Q000628:therapy
chemical_list: D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D044943:Fatty Acid Desaturases